Inactive Instrument

News PhaseRx Inc Nasdaq

Equities

US71723F1030

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Roivant Sciences GmbH cancelled the acquisition of substantially all of the assets from PhaseRx, Inc.	19-01-30	CI
PhaseRx, Inc. Bankruptcy Case Dismissed	18-03-23	CI
Motion for Case Dismissal Filed for PhaseRx, Inc.	18-03-06	CI
Motion for De Minimis Asset Sale Approved for PhaseRx, Inc.	18-02-20	CI
PhaseRx, Inc.(OTCPK:PZRX.Q) dropped from NASDAQ Composite Index	18-02-02	CI
Motion for Asset Sale Approved for PhaseRx, Inc.	18-02-01	CI
Roivant Sciences GmbH entered into an asset purchase agreement to acquire substantially all of the assets from PhaseRx, Inc. for $6.8 million.	18-01-31	CI
Bidding Procedure Approved for PhaseRx, Inc.	17-12-27	CI
PhaseRx Considers Multiple Alternatives	17-12-14	CI
PhaseRx, Inc.(NasdaqCM:PZRX) dropped from S&P TMI Index	17-12-13	CI
PhaseRx, Inc. Filed for Bankruptcy	17-12-11	CI
Motion for Asset Sale Filed by PhaseRx, Inc.	17-12-11	CI
PhaseRx, Inc. Announces Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2017	17-11-09	CI
Phaserx, Inc. Announces Termination of Michael Houston as Chief Scientific Officer	17-10-13	CI
PhaseRx, Inc. Announces Reduction of Workforce by 10 Employees	17-10-13	CI
PhaseRx Seeks Corporate Restructuring And Alternatives	17-10-13	CI
Phaserx To Cut Half Its Workforce, Looks Into Potential Merger	17-10-13	CI
PhaseRx, Inc. Appoints Robert W. Overell as Principal Accounting Officer	17-09-26	CI
PhaseRx, Inc. Announces Resignation of Shing-Yin Tsui as Senior Vice President, Finance, Secretary and Principal Accounting Officer, Effective as of September 15, 2017	17-09-08	CI
Phaserx Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2017	17-08-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News PhaseRx Inc Nasdaq

Equities

US71723F1030

Summary

Filters